Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Cystadenocarcinoma, Serous × Letrozole × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Endometrial Neoplasms 2 Carcinoma, Ductal, Breast 2 Peritoneal Neoplasms 1 Fallopian Tube Neoplasms 1 Cystadenocarcinoma, Serous 1 Carcinoma, Lobular 1 Breast Neoplasms, Male 1 Breast Carcinoma In Situ 1 Breast Cancer Invasive Nos 1

Interventions

ribociclib 1 Letrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03673124 2025-12-23

Ribociclib and Letrozole Treatment in Ovarian Cancer

GOG Foundation

Phase 2 Active not recruiting

51 enrolled 19 charts

Cystadenocarcinoma, Serous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡